Gan & Lee Pharmaceuticals. (SHSE: 603087)
Health Care · Biotechnology · CN
CN¥75.52
-2.43% today · +4.7% 1Y
Gan & Lee Pharmaceuticals. (SHSE: 603087) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.71B and employs 5,309 people.
Over the last twelve months the share price has gained 4.7%, trading between 51.51 and 79.99.
Tweenvest scores Gan & Lee Pharmaceuticals. across four factors: quality 72/100, value 41/100, growth 84/100, dividend 59/100. Its strongest factor is growth.
603087 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.71B
- Revenue (TTM)
- $619.53M
- P/E
- 38.93
- EPS
- 1.94
- Dividend yield
- 1.32%
- Beta (5Y)
- 0.26
- 52-week high
- CN¥79.99
- 52-week low
- CN¥51.51
- Avg volume (3M)
- —
- Shares outstanding
- 595.20M
- Employees
- 5,309
- Next earnings
- —
About Gan & Lee Pharmaceuticals.
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
- ISIN
- CNE100003ZH1
- Founded
- 1998
- Listed since
- Jun 29, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ionis Pharmaceuticals, Inc.NasdaqGS: IONS | $7.52B | $44.13 | -2.54% |
| Praxis Precision Medicines, Inc.NasdaqGS: PRAX | $7.26B | $254.06 | -2.23% |
| Alkermes plcNasdaqGS: ALKS | $6.81B | $40.38 | -0.57% |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd.SEHK: 2315 | $6.75B | HK$69.20 | +2.59% |
| Iovance Biotherapeutics, Inc.NasdaqGM: IOVA | $6.62B | $14.61 | -0.10% |
| Grifols, S.A.BME: GRF | $6.62B | €10.02 | +1.42% |
| Immunovant, Inc.NasdaqGS: IMVT | $6.29B | $29.81 | -2.17% |
| GRAIL, Inc.NasdaqGS: GRAL | $6.28B | $136.62 | -2.82% |
Figures last refreshed Oct 11, 2026.